Immunological Priming with Synthetic Peptides of Foot-and-Mouth Disease Virus

References

1. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of foot and mouth disease virus. Journal of Immunology 115:1635–1641
   [Google Scholar]
2. Bittle J. L., Houghten R. A., Alexander J., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot and mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
   [Google Scholar]
3. Bittle J. L., Worrell P., Houghten R. A., Lerner R. A., Rowlands D. J., Brown F. 1984; Immunization against foot and mouth disease with a chemically synthesized peptide. In Modern Approaches to Vaccines pp 103–107 Edited by Chanock R. M., Lerner R. A. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
4. Brown F., Cartwright B. 1963; Purification of radioactive foot and mouth disease virus. Nature, London 199:1168–1170
   [Google Scholar]
5. Clarke B. E., Carroll A. R., Rowlands D. J., Nicholson B. H., Houghten R. A., Lerner R. A., Brown F. 1983; Synthetic peptides mimic subtype specificity of foot and mouth disease virus. FEBS Letters 157:261–264
   [Google Scholar]
6. Cunningham A. J., Sercarz E. E. 1971; The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines. European Journal of Immunology 1:413–421
   [Google Scholar]
7. Emini E. A., Jameson B. A., Wimmer E. 1983; Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature, London 304:699–703
   [Google Scholar]
8. Francis M. J., Black L. 1983; Antibody response in pig nasal fluid and serum following foot and mouth disease infection or vaccination. Journal of Hygiene 91:329–334
   [Google Scholar]
9. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Priming with peptides of foot and mouth disease virus. In Vaccines 1985: pp 203–210 Edited by Lerner R. A., Chanock R., Brown F. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
10. Glenny A. T., Sudmersen H. J. 1921; Notes on the production of immunity to diphtheria toxin. Journal of Hygiene 20:176–220
    [Google Scholar]
11. Kennedy R. C., Dreesman G. R. 1984; Enhancement of the immune response to hepatitis B surface antigen. Journal of Experimental Medicine 159:655–665
    [Google Scholar]
12. Kurz C., Forss S., Kupper H., Strohmaier K., SChaller H. 1981; Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus. Nucleic Acids Research 9:1919–1931
    [Google Scholar]
13. Laporte J., Grosclaude J., Wantyghem J., Bernard S., Rouze P. 1973; Neutralization en culture cellulaire du pouvoie infectieux du virus de la fievre aphteuse par les serums provenant de pores immunisés a l’aide d’une proteine virale purifiee. Comptes rendus hebdomadaires des seances de l’Academie des sciences, série D 276:3399–3401
    [Google Scholar]
14. Makela O., Mitchison N. A. 1965; The role of cell number and source in adoptive immunity. Immunology 8:539–548
    [Google Scholar]
15. Mitchison N. A. 1971; The carrier effect in the secondary response to hapten protein conjugates. II. Cellular cooperation. European Journal of Immunology 1:18–27
    [Google Scholar]
16. Nossal G. J. V., Austin C. M., Ada G. L. 1965; Antigens in immunity. VII. Analysis of immunological memory. Immunology 9:333–348
    [Google Scholar]
17. Ovary Z., Benacerraf B. B. 1963; Immunological specificity of the secondary response with dinitrophenylated proteins. Proceedings of the Society for Experimental Biology and Medicine 114:72–76
    [Google Scholar]
18. Palfreyman J. W., Aitcheson T. C., Taylor P. 1984; Guidelines for the production of polypeptide specific antisera using small synthetic oligopeptides as immunogens. Journal of Immunological Methods 75:383–393
    [Google Scholar]
19. Pfaff E., Mussgay M., Bohm H. O., Schulz G. E., Schaller H. 1982; Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO Journal 1:869–874
    [Google Scholar]
20. Raff M. C. 1970; Role of thymus-derived lymphocytes in the secondary humoral immune response in mice. Nature, London 226:1257–1258
    [Google Scholar]
21. Rajewsky K., Schirrmacher M., Nase S., Jerne N. K. 1969; The requirement of more than one antigenic determinant for immunogenicity. Journal of Experimental Medicine 129:1131–1143
    [Google Scholar]
22. Rowlands D. J., Clarke B. E., Carroll A. R., Brown F., Nicholson F. B. H., Bittle J. L., Lerner R. A. 1983; Chemical basis of antigenic variation in foot and mouth disease virus. Nature, London 306:694–697
    [Google Scholar]
23. Souhami R. L., Patel H. M., Ryman B. E. 1981; The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochimica et biophysica acta 674:354–371
    [Google Scholar]
24. Strohmaier K., Franze R., Adam K. H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
25. Voller A., Bidwell D. E. 1976; Enzyme immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccinations. British Journal of Experimental Pathology 57:243–247
    [Google Scholar]
26. Wild T. F., Burroughs J. N., Brown F. 1969; Surface structure of foot-and-mouth disease virus. Journal of General Virology 4:313–320
    [Google Scholar]